US loss of exclusivity · Oncology

Keytruda

Merck

2028US biosimilars from
2025Today: 20262037
2025 worldwide sales
$31.7B
Date basis
Company guidance
US biosimilars
Filed with the FDA
Pharma Patent Cliff by readouts.io Data checked 24 October 2026 · Full Keytruda timeline →